All Stories

  1. Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications
  2. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis
  3. Calcineurin Inhibitors in the Treatment of Lupus Nephritis: A Hare Versus Turtle Story?
  4. Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy
  5. The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
  6. Update on Lupus Nephritis
  7. The interleukin-6-hepcidin-hemoglobin circuit in systemic lupus erythematosus flares
  8. Predicting decline of kidney function in lupus nephritis using urine biomarkers
  9. The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials
  10. Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare
  11. Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium
  12. The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients
  13. Renal Flare as a Predictor of Incident and Progressive CKD in Patients with Lupus Nephritis
  14. Lupus Nephritis: Induction Therapy in Severe Lupus Nephritis—Should MMF Be Considered the Drug of Choice?